• Home

MSGERC Biennial Meeting: 
Clinical Mycology Today 2020 has been postponed
to November 5 - 8, 2021

MSGERC - Biennial Meeting
November 5 - 8, 2021

Hyatt Regency Tamaya
Albuquerque, New Mexico USA

The Mycoses Study Group Education and Research Consortium (MSGERC) is comprised of dedicated physicians and scientists from around the world. Our primary goal is to champion evidence-based diagnoses, prevention, treatment and management of invasive fungal infections through education, research, and scholarship.  With membership dues of only $87.50/year ($175 payable every 2 years), we hope you will join us and become a member today.

Become a Member of MSGERC

Exclusive Benefits
of MSGERC Membership

  • Reduced registration rates for the Biennial Meeting
  • Access to MSGERC Biennial Meeting videos and presentations
  • Publishing opportunities for mycoses research on the DoctorFungus website
  • Online Membership Directory for all MSGERC members
  • Unparalleled networking opportunities with leading mycoses physicians and scientists worldwide
  • Recognition as a preferred investigator for mycology studies and clinical trials
  • Eligibility to serve as a leader on the MSGERC Board of Directors or as a Committee Chair

Contact Us! 
+1 412-343-2235   Headquarters@MSGERC.org 

DoctorFungus is the go-to resource for the latest information, education, and news in the world of medical mycology, as well as a valuable resource for patients and caregivers who are dealing with these serious and rare diseases. Provided by the MSGERC as a primary educational resource, visit www.drfungus.org to contribute to the website, read about the Case of the Month, or sign up to receive emails.


Also see Educational Opportunities under the Education Tab (msgerc.org) and funguscme.org.

MSGERC Mission

In the new era of clinical research, the MSG Education & Research Consortium will continue to champion evidence-based diagnoses, prophylaxis, treatment, and management of invasive fungal infections through its mission:


Championing excellence and innovation in the development and delivery of evidence-based medical knowledge in invasive fungal disease management for patients globally.


Translational thought leadership for the development of diagnostics and medicinal antifungals for invasive fungal infections.


Scholarly work to promote antifungal stewardship, investigational outbreak tracking, implementation science, publications, and leadership.


Study and development of antifungal therapies and diagnostics in order to address public health issues and advocate on behalf of patients, especially those diseases impacted by environmental changes and resistance.  

The majority of our images have been taken from the CDC.

(412) 344-2437

MSGERC Privacy Policy   

Powered by Wild Apricot Membership Software